ANALYSEVORRICHTUNG UND IHR GEBRAUCH

Patent europeic · EP1230550 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1230550
Numer da la dumonda
EP00978170
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-11-2000
Publitgà
14-08-2002
Concedì
25-01-2006
Stritgà
14-11-2020
Motiv
Durada maximala cuntanschida
Classas IPC
G01N 33/543 (2006.01)
B01L 3/00 (2006.01)
Prioritad
SE 9904175 18.11.1999
Dumonda PCT
PCT/SE2000/002243 15.11.2000
Publicaziun PCT
WO2001/036974 25.05.2001
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-11-2020

    Durada maximala cuntanschida

    Published in Swissreg on 16.11.2020

  2. 15-12-2006

    Adressa midada

    Owner
    Pharmacia Diagnostics AB, PO Box 6460, 751 37 Uppsala, Sweden → PHADIA AB, Box 6460, 75137 UPPSALA, Sweden

    Published in +pat+ No 23 in 2006

  3. 15-05-2006

    Represchentant inscrit

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 9 in 2006

  4. 31-01-2006

    Concedì

    Published in +pat+ No 2 in 2006

Partidas

Inventur

MENDEL-HARTWIG, Ib

S-756 55 Uppsala, SE

BJÖRKMAN, Rune

S-752 36 Uppsala, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.